Skip to content

Author

Mu-Tian Tang

We have 1 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Targeting splicing-derived neoantigens for precision cancer immunotherapy

This review integrates current understanding of the biological origins, immunological barriers, target classes of splicing neoantigens, and the technologies that enable their advancement in cancer immunotherapy to produce two major classes of immunotherapeutic targets.

Mu-Tian Tang, H. L. Grimes, Nathan Salomonis · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.